
R42 Group
Description
R42 Group is a distinctive deep science venture firm headquartered in Stanford, California, operating with a dual model as both a venture studio and a venture capital fund. Their core mission revolves around actively inventing, building, and financing pioneering deep science ventures designed to tackle some of humanity's most pressing challenges. This approach distinguishes them from traditional VC firms, as they are not merely investors but also active participants in the creation and development of new companies, aiming to foster groundbreaking innovation from inception.
The firm's investment thesis is sharply focused on several high-impact technological domains. These include artificial intelligence (AI), biotechnology, robotics, space exploration, and quantum computing. R42 Group strategically partners with leading universities and research institutions, leveraging academic breakthroughs and cutting-edge research to identify and commercialize groundbreaking technologies. This collaborative ecosystem allows them to access a pipeline of innovative ideas at their nascent stages, demonstrating a commitment to long-term, foundational advancements.
In terms of investment strategy, R42 Group primarily targets companies at the pre-seed and seed stages of development. Their initial capital commitments typically range from $250,000 to $2 million, providing crucial early-stage funding for deep tech startups that often require significant capital and long development cycles. Beyond these initial investments, R42 Group is prepared to make substantial follow-on investments in subsequent funding rounds, demonstrating a long-term commitment to their portfolio companies as they scale and mature. To date, their active engagement has resulted in approximately 17 reported investments across their various focus areas, showcasing their consistent activity in the deep science ecosystem.
This integrated model allows R42 Group to provide more than just capital; they offer hands-on support in company formation, strategic guidance, and access to a network of scientific and entrepreneurial expertise. Their dedication to deep science, combined with a flexible investment structure that accommodates both early-stage risk and long-term growth, positions R42 Group as a key player in fostering the next generation of transformative technologies.
Investor Profile
R42 Group has backed more than 25 startups, with 2 new investments in the last 12 months alone. The firm has led 5 rounds, about 20% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Switzerland.
- Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
- Led 1 rounds in the past year.
- Typical check size: $250K – $2M.
Stage Focus
- Seed (56%)
- Series A (16%)
- Pre Seed (12%)
- Series Unknown (8%)
- Series C (4%)
- Convertible Note (4%)
Country Focus
- United Kingdom (64%)
- United States (28%)
- Switzerland (8%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Life Science
- Medical
- Pharmaceutical
- Information Technology
- Software
- Biopharma
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.